Cefmenoxime


Concise Prescribing Info
Indications/Uses
Susceptible infections.
Dosage/Direction for Use
Adult : IV/IM 1-4 g/day in 2-4 divided doses. Up to 9 g/day in severe infections.
Dosage Details
Parenteral
Susceptible infections
Adult: 1-4 g daily IM/IV by Inj or infusion in 2-4 divided doses, up to 9 g daily for severe infections.
Child: 40-80 mg/kg/day in 2-4 divided doses, higher doses may be used in severe infections. Neonates: 40-60 mg/kg/day in 2-3 divided doses.
Contraindications
Hypersensitivity to cephalosporins.
Special Precautions
Hypersensitivity to penicillins; renal impairment; porphyria. Monitor renal and hematologic status. Pregnancy and lactation.
Adverse Reactions
Nausea; vomiting; diarrhoea; hypersensitivity reactions; nephrotoxicity; convulsions; CNS toxicity; hepatic dysfunction; haematologic disorders; pain at Inj site (IM); thrombophloebitis (IV infusion); superinfection with prolonged use.
Potentially Fatal: Pseudomembranous colitis.
Drug Interactions
Renal clearance reduced by probenecid. Disulfiram-like reactions with alcohol.
Lab Interference
Positive direct antiglobulin Coombs' test; falsely high values with Jaffe method of measuring creatinine concentrations; +ve reactions for false glucose using copper-reduction reactions; transient increases in liver enzyme values.
Action
Description: Cefmenoxime inhibits final cross-linking stage of peptidoglycan production through binding and inactivation of transpeptidases on the inner surface of the bacterial cell membrane thus inhibiting bacterial cell wall synthesis. It is highly stable to hydrolysis by most β-lactamases.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Cefmenoxime from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in